V Miriagou
Overview
Explore the profile of V Miriagou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Voulgari E, Kotsakis S, Giannopoulou P, Perivolioti E, Tzouvelekis L, Miriagou V
Euro Surveill
. 2020 Jan;
25(2).
PMID: 31964461
Two ceftazidime-avibactam (CAZ-AVI)-resistant carbapenemase (KPC)-positive strains, including one pandrug resistant, were isolated in 2019 from two Greek hospitals. The strains were sequence types (ST)s 258 and 147 and both harboured...
2.
Piperaki E, Tzouvelekis L, Miriagou V, Daikos G
Clin Microbiol Infect
. 2019 Mar;
25(8):951-957.
PMID: 30914347
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated patients, causing pneumonia and bloodstream infections with high mortality rates. Difficulties...
3.
Sarrou S, Liakopoulos A, Tsoumani K, Sagri E, Mathiopoulos K, Tzouvelekis L, et al.
Antimicrob Agents Chemother
. 2015 Nov;
60(2):1164-6.
PMID: 26596938
No abstract available.
4.
Kotsakis S, Miriagou V, Vetouli E, Bozavoutoglou E, Lebessi E, Tzelepi E, et al.
Antimicrob Agents Chemother
. 2015 Oct;
59(12):7894-8.
PMID: 26438499
The cephalosporinase CMY-107, a Tyr199Cys mutant form of CMY-2 encoded by an IncI self-transferable plasmid carried by an Escherichia coli clinical strain, was characterized. The enzyme hydrolyzed oximino-cephalosporins and aztreonam...
5.
Kotsakis S, Tzouvelekis L, Lebessi E, Doudoulakakis A, Bouli T, Tzelepi E, et al.
Antimicrob Agents Chemother
. 2015 Feb;
59(5):2964-6.
PMID: 25691650
No abstract available.
6.
Vingopoulou E, Siarkou V, Batzias G, Kaltsogianni F, Sianou E, Tzavaras I, et al.
J Antimicrob Chemother
. 2014 Apr;
69(8):2076-80.
PMID: 24722836
Objectives: To characterize the mechanisms implicated in fluoroquinolone (FQ) and expanded-spectrum cephalosporin (ESC) resistance in three clinical and seven faecal multidrug-resistant (MDR; resistant to at least three antimicrobial classes) Escherichia...
7.
Papagiannitsis C, Kotsakis S, Tuma Z, Gniadkowski M, Miriagou V, Hrabak J
Antimicrob Agents Chemother
. 2014 Feb;
58(5):2952-7.
PMID: 24566177
This study exploited the possibility to detect Citrobacter freundii-derived CMY-2-like cephalosporinases in Enterobacteriaceae clinical isolates using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Periplasmic proteins were prepared...
8.
Tzouvelekis L, Miriagou V, Kotsakis S, Spyridopoulou K, Athanasiou E, Karagouni E, et al.
Antimicrob Agents Chemother
. 2013 Jul;
57(10):5144-6.
PMID: 23856769
The virulence of a KPC-producing Klebsiella pneumoniae sequence type 258 (ST258) strain representing those circulating in Greece was assessed in a mouse septicemia model. The strain was virtually avirulent (50%...
9.
Papagiannitsis C, Miriagou V, Giakkoupi P, Tzouvelekis L, Vatopoulos A
J Antimicrob Chemother
. 2013 May;
68(10):2259-62.
PMID: 23711894
Objectives: To determine the complete nucleotide sequence of the VIM-1-encoding plasmid pKP1780 from Klebsiella pneumoniae ST147 representing a distinct group of IncR replicons. Methods: The plasmid pKP1780 was from a...
10.
Papagiannitsis C, Miriagou V, Giakkoupi P, Tzouvelekis L, Vatopoulos A
Antimicrob Agents Chemother
. 2013 May;
57(7):3427-9.
PMID: 23629721
The nucleotide sequence of pKP1433 (55,417 bp), a blaKPC-2-carrying plasmid from Klebsiella pneumoniae sequence type 340, was determined. pKP1433 displayed extensive sequence and structural similarities with the IncN plasmids possessing...